36 related articles for article (PubMed ID: 31339189)
1. Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
Williams A; Cooper E; Clark B; Perry L; Ponassi M; Iervasi E; Brullo C; Greenhough A; Ladomery M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791418
[TBL] [Abstract][Full Text] [Related]
2. Development of antitumor biguanides targeting energy metabolism and stress responses in the tumor microenvironment.
Sakai T; Matsuo Y; Okuda K; Hirota K; Tsuji M; Hirayama T; Nagasawa H
Sci Rep; 2021 Mar; 11(1):4852. PubMed ID: 33649449
[TBL] [Abstract][Full Text] [Related]
3. Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.
Guo Z; Sevrioukova IF; Denisov IG; Zhang X; Chiu TL; Thomas DG; Hanse EA; Cuellar RAD; Grinkova YV; Langenfeld VW; Swedien DS; Stamschror JD; Alvarez J; Luna F; Galván A; Bae YK; Wulfkuhle JD; Gallagher RI; Petricoin EF; Norris B; Flory CM; Schumacher RJ; O'Sullivan MG; Cao Q; Chu H; Lipscomb JD; Atkins WM; Gupta K; Kelekar A; Blair IA; Capdevila JH; Falck JR; Sligar SG; Poulos TL; Georg GI; Ambrose E; Potter DA
Cell Chem Biol; 2017 Oct; 24(10):1259-1275.e6. PubMed ID: 28919040
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate elicits pro-respiratory and anti-growth effects by promoting AMPK signaling.
Papadopoli DJ; Ma EH; Roy D; Russo M; Bridon G; Avizonis D; Jones RG; St-Pierre J
Sci Rep; 2020 May; 10(1):7838. PubMed ID: 32398698
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and anti-proliferative mechanism of fluorine-containing proguanil derivatives.
Xiao D; Lu Z; Wang Z; Zhou S; Cao M; Deng J; Hu X; Peng M; He C; Wu J; Xu S; Zhang H; Xu C; Wang W; Guan A; Yang X
Bioorg Med Chem; 2020 Jan; 28(2):115258. PubMed ID: 31864776
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.
Zhang Y; Wu C; Zhang N; Fan R; Ye Y; Xu J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628906
[TBL] [Abstract][Full Text] [Related]
7. In Silico Identification of Promising New Pyrazole Derivative-Based Small Molecules for Modulating CRMP2, C-RAF, CYP17, VEGFR, C-KIT, and HDAC-Application towards Cancer Therapeutics.
Bennani FE; Karrouchi K; Doudach L; Scrima M; Rahman N; Rastrelli L; Tallei TE; Rudd CE; Faouzi MEA; Ansar M
Curr Issues Mol Biol; 2022 Oct; 44(11):5312-5351. PubMed ID: 36354673
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage.
Zhou S; Li D; Xiao D; Wu T; Hu X; Zhang Y; Deng J; Long J; Xu S; Wu J; Li G; Peng M; Yang X
Int J Biol Sci; 2022; 18(4):1555-1568. PubMed ID: 35280680
[TBL] [Abstract][Full Text] [Related]
9. Synthetic accesses to biguanide compounds.
Grytsai O; Ronco C; Benhida R
Beilstein J Org Chem; 2021; 17():1001-1040. PubMed ID: 34025808
[TBL] [Abstract][Full Text] [Related]
10. Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics.
Ghoneum A; Abdulfattah AY; Warren BO; Shu J; Said N
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354000
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Anti-Proliferative Evaluation and Mechanism of 4-Trifluoro Methoxy Proguanil Derivatives with Various Carbon Chain Length.
Xu S; Cao Y; Luo Y; Xiao D; Wang W; Wang Z; Yang X
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641319
[TBL] [Abstract][Full Text] [Related]
12. Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.
Narise K; Okuda K; Enomoto Y; Hirayama T; Nagasawa H
Drug Des Devel Ther; 2014; 8():701-17. PubMed ID: 24944508
[TBL] [Abstract][Full Text] [Related]
13. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.
Arkwright RT; Deshmukh R; Adapa N; Stevens R; Zonder E; Zhang Z; Farshi P; Ahmed RS; El-Banna HA; Chan TH; Dou QP
Anticancer Agents Med Chem; 2015; 15(5):657-71. PubMed ID: 25511514
[TBL] [Abstract][Full Text] [Related]
14. Biguanides: Species with versatile therapeutic applications.
Kathuria D; Raul AD; Wanjari P; Bharatam PV
Eur J Med Chem; 2021 Jul; 219():113378. PubMed ID: 33857729
[TBL] [Abstract][Full Text] [Related]
15. Anticancer properties of novel pyrazole-containing biguanide derivatives with activating the adenosine monophosphate-activated protein kinase signaling pathway.
Zhou S; Xu L; Cao M; Wang Z; Xiao D; Xu S; Deng J; Hu X; He C; Tao T; Wang W; Guan A; Yang X
Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900075. PubMed ID: 31339189
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Anticancer Activities, and Mechanism of N-heptyl-containing Biguanide Derivatives.
Wang W; Xiao D; Zhou S; Xu S; Tang X; Zhou X; Liu J; Xu C; Peng M; Yang X
Med Chem; 2022; 18(8):895-902. PubMed ID: 35142271
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
